Overexpression of AmpC and Efflux Pumps in Pseudomonas aeruginosa Isolates from Bloodstream Infections: Prevalence and Impact on Resistance in a Spanish Multicenter Study
- 1 May 2011
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 55 (5), 1906-1911
- https://doi.org/10.1128/aac.01645-10
Abstract
The prevalence and impact of the overexpression of AmpC and efflux pumps were evaluated with a collection of 190 Pseudomonas aeruginosa isolates recovered from bloodstream infections in a 2008 multicenter study (10 hospitals) in Spain. The MICs of a panel of 13 antipseudomonal agents were determined by microdilution, and the expressions of ampC , mexB , mexY , mexD , and mexF were determined by real-time reverse transcription (RT)-PCR. Up to 39% of the isolates overexpressed at least one of the mechanisms. ampC overexpression (24.2%) was the most prevalent mechanism, followed by mexY (13.2%), mexB (12.6%), mexF (4.2%), and mexD (2.2%). The overexpression of mexB plus mexY , documented for 5.3% of the isolates, was the only combination showing a significantly ( P = 0.02) higher prevalence than expected from the frequencies of the individual mechanisms (1.6%). Additionally, all imipenem-resistant isolates studied (25 representative isolates) showed inactivating mutations in oprD . Most of the isolates nonsusceptible to piperacillin-tazobactam (96%) and ceftazidime (84%) overexpressed ampC , while mexB (25%) and mexY (29%) overexpressions gained relevance among cefepime-nonsusceptible isolates. Nevertheless, the prevalence of mexY overexpression was highest among tobramycin-nonsusceptible isolates (37%), and that of mexB was highest among meropenem-nonsusceptible isolates (33%). Regarding ciprofloxacin-resistant isolates, besides the expected increased prevalence of efflux pump overexpression, a highly significant link to ampC overexpression was documented for the first time: up to 52% of ciprofloxacin-nonsusceptible isolates overexpressed ampC , sharply contrasting with the 24% documented for the complete collection ( P < 0.001). In summary, mutation-driven resistance was frequent in P. aeruginosa isolates from bloodstream infections, whereas metallo-β-lactamases, detected in 2 isolates (1%) producing VIM-2, although with increasing prevalences, were still uncommon.Keywords
This publication has 34 references indexed in Scilit:
- Efflux Pumps, OprD Porin, AmpC β-Lactamase, and Multiresistance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis PatientsAntimicrobial Agents and Chemotherapy, 2010
- Caracterización molecular de aislados clínicos de Pseudomonas aeruginosa productores de la metalobetalactamasa VIM-2 en Cantabria, EspañaEnfermedades Infecciosas y Microbiología Clínica, 2010
- Antibacterial-ResistantPseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance MechanismsClinical Microbiology Reviews, 2009
- Role of Efflux Pumps and Mutations in Genes for Topoisomerases II and IV in Fluoroquinolone-ResistantPseudomonas aeruginosaStrainsMicrobial Drug Resistance, 2003
- VIM- and IMP-Type Metallo-ß-lactamase–ProducingPseudomonasspp. andAcinetobacterspp. in Korean HospitalsEmerging Infectious Diseases, 2003
- Mechanisms of Decreased Susceptibility to Cefpodoxime in Escherichia coliAntimicrobial Agents and Chemotherapy, 2002
- Mutation and Evolution of Antibiotic Resistance: Antibiotics as Promoters of Antibiotic Resistance?Current Drug Targets, 2002
- Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?Clinical Infectious Diseases, 2002
- Genes Encoding TEM-4, SHV-2, and CTX-M-10 Extended-Spectrum β-Lactamases Are Carried by MultipleKlebsiella pneumoniaeClones in a Single Hospital (Madrid, 1989 to 2000)Antimicrobial Agents and Chemotherapy, 2002
- Involvement of an Active Efflux System in the Natural Resistance of Pseudomonas aeruginosa to AminoglycosidesAntimicrobial Agents and Chemotherapy, 1999